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The Metabolic Syndrome: A Modern
Plague Spread by Modern Technology
Aaron Spalding, MD, PhD;1 Joseph Kernan, BA, MS;2 Warren Lockette, MD2,3,4
Malnutrition and infectious disease represent the
most common health threats facing the develop-
ing world. However, increasing technological
developments and the expansion of western cul-
ture have contributed to the increasing prevalence
of the metabolic syndrome. The epidemiologic
significance and potential costs to governmental
health care systems of an increasing incidence of
metabolic syndrome could become high. The role
of environmental influences that lead to the
development of the metabolic syndrome needs to
be explored. Because the metabolic syndrome
becomes more common as nations develop, inves-
tigations into the ramifications of this disease
often come too late. J Clin Hypertens (Greenwich).
2009;11:755–760. ª2009 Wiley Periodicals, Inc.
Everyone loves a good mystery. No one knowswith certainty the population of the pre-
Columbian New World, nor the extent of popu-
lation changes since the 1500s. Estimates have
ranged from a conservative low of 8 million, to a
high of 145 million; the most common consensus
is that approximately 54 million indigenous Indi-
ans populated the Americas during the initial
Spanish conquest. During the 16th century, there
were 3 distinct major population collapses in
Mexico at that time. Approximately 8 million
deaths occurred in 1520, 12 to 15 million more
deaths followed in 1545, and, subsequently,
evidence shows that there were an additional
2 million deaths in 1576. These numbers are sig-
nificant no matter what size one considers to
have been the pre-Columbus population of
Central and South America.1 What caused the
deaths of so many?
There has been long-standing consensus that
most of these losses were due to communicable dis-
eases, and, until recently, most fingers pointed to
diseases imported to the New World—either from
smallpox, typhus, or measles—despite lacking proof
of ‘‘who done it.’’ However, could indigenous
microbes have been responsible? Recent evidence
suggests that a nascent disease, whose spread was
facilitated by the actions of the Spanish, was indeed
responsible for these later epidemics. Most likely,
these latter depopulations, sufficiently severe at that
time to warrant a new name, cocoliztli in the native
Nahuatl ⁄Aztec vernacular, is now felt to be the
result of indigenous viral hemorrhagic fevers whose
spread was eased by rodent hosts during extreme
drought conditions.2,3 This conclusion was finally
made possible by the astute observations of some
infectious disease specialists who noted that pat-
terns of drought affected the outbreak of lethal
infections caused by the Sin Nombre virus in the
Four Corners region of the United States in 1993.
The cultural, social, and political transformation of
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Mesoamerica brought about by the Spanish, cou-
pled with the effect of a changing climate in the
region, created conditions favorable for these epi-
demics in 16th century Mexico. Two medical histo-
rians recently noted:
[The] concentration of previously dispersed
rural populations into new towns centered
around churches, the centralization of food
supplies, changes in crop production in con-
cert with ecological events (deforestation,
droughts, dust storms) may have fostered
selective disease spread among the indige-
nous peoples.... Large-scale depopulation led
to a destruction of local agrarian infrastruc-
tures which fostered and sustained these epi-
demics, and disease foci receded and then
disappeared....2
As the end of this mystery unfolds, another one
begins in the 21st century. Although problems
brought about by infectious diseases remain preva-
lent in many regions of Central and South America,
recent cultural, social, and political transformations
have brought about the rise of a new epidemic, the
metabolic syndrome. The lesson learned from the
infectious disease specialists, vide supra, is helpful
in framing how we view this new epidemic and




The metabolic syndrome is a group of traits that
occur together and promote the development of
diabetes mellitus and cardiovascular disease. Specifi-
cally, patients with the metabolic syndrome have a
5-fold increased risk of type II diabetes mellitus and
a 2-fold increased risk of cardiovascular disease.
The recent geometric growth of the metabolic syn-
drome (Table) in developing countries has been
attributed, for the most part, to the import of tech-
nology and cultural adaptations that have pro-
moted industrialization. Indeed, those countries
that are the most industrialized have the greatest
prevalence of the metabolic syndrome. However,
our mystery has taught us that we must look at
both indigenous and imported contributions to
understand the development of this latest epidemic.
This exercise is important. Identification of
patients with the metabolic syndrome may help
determine which individuals should receive interven-
tions when resources in a developing country are
scant. The constellation of findings in patients with
the metabolic syndrome—high levels of plasma
insulin, impaired glucose tolerance, hyperlipidemia
(ie, increased triglycerides [very low-density lipopro-
tein] with low levels of high-density lipoprotein
cholesterol [HDL-C]), and high blood pressure—
was originally called syndrome X, and it has also
been called the insulin resistance syndrome. Other
criteria may be added to the definition of the
metabolic syndrome, such as central obesity (ie,
increased waist circumference for men of >40 in
and for women >35 in), microalbuminuria, or a
procoagulant state that could be reflected by a num-
ber of factors such as increased plasma fibrinogen
concentrations.4 Also, in addition to diabetes mell-
itus and cardiovascular disease, other abnormalities
have been associated with the metabolic syndrome
such as nonalcoholic fatty liver disease. The
mechanisms by which this syndrome and its conse-
quences develop are unknown.
POTENTIAL INHERITABLE RISK FACTORS
A genetic predisposition to the metabolic syndrome
can explain some, but not all, of the increasing
prevalence of this disorder in the developing world.
For example, one cross-sectional survey of a ran-
dom representative sample from each health district
in Zulia State, Venezuela, showed a high overall
prevalence of the metabolic syndrome (31%). The
occurrence of the metabolic syndrome revealed a
distinct ethnic predisposition; Amerindian men had
a prevalence of only 17%, whereas men of mixed
Hispanic descent had more than twice the rate
(37.4%).5 With industrialization, it will be of inter-
est to know whether the indigenous populations
are more or less susceptible to the development of
the metabolic syndrome.
Others have described sex-specific risks towards
developing the metabolic syndrome. Premenopausal
women seem to resist the development of the
metabolic syndrome, but this protection disappears
after menopause.6 Hormonal manipulation of
experimental animals points to a link between
estrogen, testosterone, and development of meta-
bolic syndrome markers. Rats overfed with a
sucrose diet develop metabolic syndrome mani-
fested by increased blood pressure, proteinuria, and
lipid peroxidation. The severity of the metabolic
syndrome correlated with decreased expression of
enzymes that reduce free radicals. Most interest-
ingly, oophorectomy decreased the protection
against oxidative stress in females; the opposite
occurred in castrated males.7 These laboratory and
clinical studies suggest that testosterone increases
susceptibility to the metabolic syndrome, whereas
estrogen may be protective.
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Epidemiologic studies have shown an inverse
correlation between birth weight and cardiovascular
disease. Perhaps early life stressors, such as poor
maternal nutrition, maternal obesity, and rapid
postnatal weight gain program metabolic adapta-
tions for subsequent survival in a nutrient-poor
environment such as would occur during a drought.
However, when calories are later plentiful, this
same programming results in the metabolic syn-
drome in adolescents and adults. Accordingly,
increasing food consumption and calories could
contribute to the appearance of the metabolic syn-
drome in individuals so predisposed because they
were stressed during intrauterine life.8–11 As indus-
trialization has led to higher per capita income,
food availability has increased, consistent with this
hypothesis. Furthermore, the primary focus in pre-
venting the metabolic syndrome should be to
ensure adequate maternal nutrition.
However, as practitioners in the developing
world, we have learned the lesson taught by our
study of the epidemiology of infectious diseases: we
must not forget to look at all ways the environment
shapes the presentation of disease. We postulate
that poorly regulated environmental factors in some
developing regions, primarily environmental pollu-
tants, can also contribute to the growing problem
of the metabolic syndrome in the developing world.
ENVIRONMENTAL EXPOSURE TO
ORGANIC TOXINS AS INSULIN DISRUPTORS
In most cases, the exact environmental pollutants
associated with the development of the metabolic
syndrome are not known. For example, individuals
working in petrochemical plants in Brazil and Ven-
ezuela have been shown to have a high incidence
of the metabolic syndrome.12,13 In these cases,
exposure to various industrial chemicals such as
benzene, xylene, ethylene, and vinyl chloride was
noted. Working in these types of plants is often not
necessary for one to be at increased risk for the
metabolic syndrome; just living in residential areas
surrounding industrial areas increases the risk of
the metabolic syndrome.14 Benzene derivatives
induce hyperinsulinemia in a dose-dependent man-
ner in animal experiments. This could potentially
contribute to the insulin resistance found in the
metabolic syndrome.15
Although association does not prove causation,
recent findings suggest a cause and effect relation-
ship between environmental pollutants and suscep-
tibility to the metabolic syndrome. For example,
bisphenol A is one of the highest volume chemicals
produced in the world. It is an essential ingredient
in the production of plastic polymers and is used in
the manufacturing of food and beverage containers.
It is found in significant concentration in the urine
of 95% of people living in the United States and it
has been shown that exposure of laboratory ani-
mals to doses about 1000-fold less than what is
allowed by the US Environmental Protection
Agency alters glucose tolerance and induces insulin
resistance.16,17 Bisphenol A affects the expression of
the glut4 cell membrane glucose transporter in
cultured adipocytes, increasing glucose uptake and
adipogenesis.18 So concerned with the public health
implication of this finding, Canada has even taken
steps to ban baby bottles manufactured with this
chemical.19
Similarly, dioxins are lipophilic organochlorine
compounds that accumulate virtually irreversibly in
fat tissue. Humans are ubiquitously exposed to
dioxins through a number of sources. For example,
these compounds are used in the processing of tim-
ber or manufacturing of paper, the production of
herbicides, or through improper disposal of prod-
ucts made from plastics. Because dioxins are stored
in fat tissue, almost all humans examined have
Table. Worldwide Estimates of the Metabolic Syndrome Among Countries With Recent Industrialization
Country Ages, y Incidence, Male, % Incidence, Female, % Reference
Korea 40–60 17 10 Sung et al.37
Brazil 60–79 64 44 Dalacorte et al.38
Brazil 6–10 9a Strufaldi et al.39
Bolivia 5–18 40 32 Caceres et al.40
Chile 30–60 39 34 Mujica et al.41
Colombia 41 (average) 33a Pinzón et al.42
Mexico 35–65 41b Ramı́rez-Vargas et al.43
Mexico 20–40 49 43 Echavarrı́a-Pinto et al.44
Mexico 35–64 40 60 Lorenzo et al.45
aThe sex of participants was not reported in this study. bFemale patients were not included in this study.
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detectable burdens of dioxins. Experimental evi-
dence has linked dioxin exposure to impaired glu-
cose transport, and it is likely that long-term low
level exposure to dioxin is a risk factor for glucose
intolerance and insulin resistance.20 The strongest
data in support of this link come from a govern-
ment study of US Air Force veterans who partici-
pated in ‘‘Operation Ranch Hand.’’ These
personnel had contact with a dioxin contaminant
in an herbicide, Agent Orange. Compared with a
control population, these veterans had a 3-fold
increase in dioxin levels, 12 parts per trillion, com-
pared with the control group of patients, 4 parts
per trillion. Despite the trace amount of dioxin
present, the exposed group had greatly increased
rates of glucose intolerance, type II diabetes mell-
itus, the development of diabetes at an earlier age,
and abnormalities in plasma insulin concentra-
tions.21 In vitro experiments clearly demonstrate
dioxin selectively targets the pancreatic b cells, to
disrupt insulin secretion, and at high levels cause
islet cell death.22 At levels found in serum of
exposed humans, dioxin decreases expression of
glut4 in pancreatic islet cells, disrupting the nega-
tive feedback loop for insulin secretion, potentially
leading to hyperinsulinemia.23
The problem of environmental contamination is
not limited to North America. There is widespread
contamination by these compounds in the marine
environment throughout the coastal waters of
South America,24 and levels have been so high in
some South American products that their exports
were halted.25 Because the metabolic syndrome
can represent a prediabetic state, it is worrisome
that these compounds could facilitate the develop-
ment of the metabolic syndrome and diabetes
mellitus.
HEAVY METAL EXPOSURE
It is not only organic chemicals that may predispose
an individual to the metabolic syndrome. It has
been known for some time that environmental
exposure to lead and cadmium is associated with
higher blood pressure, especially in the Hispanic
population, and the heavy metals also potentiate
the development of renal insufficiency (eg, saturnine
nephropathy). Accordingly, lead may contribute to
the higher blood pressures found in patients with
the metabolic syndrome.26–28 Similarly, organic
mercurials are widely found as environmental pol-
lutants. Although there is no evidence that organic
mercurials contribute to the direct evolution of
glucose intolerance to the metabolic syndrome,
mercury exposure could increase the untoward
sequelae of full-blown diabetes, such as peripheral
neuropathy, that may occur in these patients.
Of all of the heavy metals that contaminate the
environment, both from natural sources such as
groundwater and that which is a byproduct of min-
ing operations, arsenic exposure most strongly pre-
disposes one toward the metabolic syndrome, at
levels below which are considered toxic. Arsenic
contamination of drinking water has been linked in
several areas to insulin resistance. A study of 660
random people from central Taiwan showed that
after adjustment for age, sex, occupation, and life-
style factors including cigarette smoking (a princi-
pal cause of heavy metal exposure), arsenic levels
correlated with the prevalence of the metabolic syn-
drome. Furthermore, arsenic concentrations had a
linear relationship with increasing levels of plasma
glucose, plasma lipids, and blood pressure. A study
performed in the United States investigated the
association of very mild arsenic exposure, as
measured with urinary arsenic excretion, with the
prevalence of type II diabetes mellitus. This cross-
sectional study of 788 adults found that the median
urine level of total arsenic was 7.1 lg ⁄L, with a
prevalence of type II diabetes mellitus of 7.7%.
After adjustment for diabetes risk factors and
markers of seafood intake, patients with type II dia-
betes had a 26% higher level of total arsenic than
participants who were euglycemic. After similar
adjustments, the odds ratio for type II diabetes
comparing participants at the 80th vs the 20th per-
centiles of arsenic load was 3.58 for the level of
total arsenic. That study concluded that the low
levels of exposure to inorganic arsenic in otherwise
‘‘safe’’ drinking water may play a role in the inci-
dence of diabetes. Arsenic has similarly been linked
to the progression of the metabolic syndrome and
diabetes in other countries. A case-control study in
an arsenic-endemic region from Coahuila, a north-
ern state in Mexico with a high incidence of diabe-
tes, was conducted that included 200 cases and
200 controls. Patients with higher urinary arsenic
concentrations had a 2- to 3-fold higher risk of
having type II diabetes mellitus, as indicated by
fasting glucose values >126 mg ⁄dL, or the use of
insulin or oral hypoglycemic agents.29–33
Laboratory data suggest that arsenic, similar to
dioxin, specifically alters glucose homeostasis through
targeting pancreatic b cells. Downstream signaling of
the insulin receptor relies on kinase activity. Arsenic
inhibits phosphorylation of Akt at both threonine
308 and serine 473 after insulin exposure, desensitiz-
ing cells to insulin.34 Rats exposed to arsenic in their
drinking water to mimic industrial exposure develop
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hyperglycemia and decreased insulin secretion, with
increased islet cell apoptosis.35 In islet cells, cell death
and decreased insulin secretion could produce
hyperglycemia. Coupled with target cell insulin desen-
sitivity, arsenic exposure can lead to the metabolic
syndrome.
CONCLUSIONS
Molecular genetics has shown us that traits such as
glucose intolerance, insulin resistance, and blood
pressure are complex quantitative traits. That is,
there are several genes that contribute to our herita-
ble predisposition for each of these phenotypes, and
there are obvious environmental contributions to
the metabolic syndrome, such as the intake of
excess calories or low levels of exertion and exer-
cise. However, the role of environmental pollutants,
both naturally occurring and man-made, should be
further investigated.
It is recognized in many developing areas where
the metabolic syndrome is becoming endemic that
there is no infrastructure in place or resources to sup-
port such inquiry. Fortunately, it has been shown
that laboratory-based tests, ie, blood sampling, are
not needed to determine an individual’s cardiovascu-
lar disease risk. A careful survey can be equally reli-
able.36 As individuals who provide humanitarian
assistance to the health care infrastructure of the
developing world, we must be reminded that our
evaluation and counseling of patients predisposed to
diabetes and the metabolic syndrome in resource-
poor environments should have a broad perspective.
Despite the lack of internal resources, it would be
helpful if those who perform humanitarian medical
assistance to developing regions of the globe also
help to assess and document the growing risk for the
metabolic syndrome. Specifically, we urge those
agencies that support such programs to help facilitate
environmental assessments during those missions for
the risk factors we have described above. Data gener-
ated in such a manner can be used to help host
nations plan their interventions at diminishing the
untoward effects of diabetes mellitus and cardiovas-
cular disease. When we examine patients, we must
remember to examine the environment in which they
live. We can learn much by lessons taught to us by
our colleagues who specialize in infectious disease.
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Prevalence of the metabolic syndrome and associated life-
styles in adult males from Oaxaca, Mexico. Salud Publica
Mex. 2007;49:94–102.
44 Echavarrı́a-Pinto M, Hernández-Lomelı́ A, Alcocer-
Gamba MA, et al. Metabolic syndrome in adults from 20
to 40 years old in a rural Mexican community. Rev Med
Inst Mex Seguro Soc. 2006;44:329–335.
45 Lorenzo C, Williams K, Gonzalez-Villalpando C, et al.
The prevalence of the metabolic syndrome did not
increase in Mexico City between 1990–1992 and 1997–
1999 despite more central obesity. Diabetes Care. 2005;
28:2480–2485.
THE JOURNAL OF CLINICAL HYPERTENSION VOL. 11 NO. 12 DECEMBER 2009760
